• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, October 4, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Biochemists zero in on key molecules that enable cells to crawl

Bioengineer by Bioengineer
March 5, 2018
in Biology
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

EUGENE, Ore. — March 5, 2018 — Biochemists have made a discovery that sheds light on the molecular machinery that allows some cells, such as immune cells or even malignant cancer cells in humans, to wiggle their way through tissues like organs, skin or bones.

The work, conducted in the University of Oregon laboratory of Brad Nolen, a professor in the Department of Chemistry and Biochemistry, was described in a paper in the Feb. 13 issue of the Proceedings of the National Academy of Sciences.

The researchers examined a fibrous rope-like protein in cells called actin, which grows and branches the way limbs on trees do. When actin branches grow, they push on the cell membrane and create arm-like protrusions. These arms can pull an immune cell forward, allowing it to chase foreign invaders and wrap around and swallow them.

Nolen and colleagues looked at the actin-related complex, Arp2/3, a large assembly of proteins that is required for actin to branch. When Arp2/3 sits down on actin it promotes a new branch to form at that site.

This Arp2/3 complex is critical to cell motility — the ability to move and perform myriad duties — and for initializing the construction of a network of filaments known as the actin cytoskeleton that provides structural support for cells.

The researchers identified two locations on Arp2/3 where an activator protein touches it. This activator protein resides in the membrane and can sense when the cell needs to crawl or engulf a foreign agent. It then triggers the branching response inside of the cell by touching Arp2/3.

To find the precise locations where the activator protein meets Arp2/3, the research team extracted Arp2/3 and the activator protein from cells, mixed them together, and used a special method that chemically marks the two proteins at the sites where they touched. In collaboration with researchers at the University of Washington, the team zeroed in on the location of those marks using a technique called mass spectrometry.

"What we discovered was exciting because knowing precisely how the activator protein binds to Arp2/3 complex is the first step in understanding how it turns on its branching activity," Nolen said.

Understanding how this branching activity is turned on in malignant cells could be applicable in the development of new drugs to target cancer, the researchers said. In some disease states, including viral infections such as HIV and cancer, cells can lose control of their actin cytoskeleton.

For example, Nolen said, a drug that blocks the site on Arp2/3 where the activator protein touches would prevent actin branching. That could stop tumor cells from crawling, or metastasizing.

Pharmaceutical companies used similar approaches to develop paclitaxel, a cancer drug that targets another filament-forming protein called tubulin. Nolen and his colleagues said that their findings could eventually lead to new opportunities to improve human health by expanding the arsenal of disease-fighting drugs.

###

Qing Luan, a senior research assistant in Nolen's group in the UO Institute of Molecular Biology and Department of Chemistry and Biochemistry, and Alex Zelter, a research scientist in the Department of Biochemistry at the University of Washington, were lead authors on the paper. Other co-authors were Michael J. MacCoss of the Department of Genome Sciences at the University of Washington, and Trisha N. Davis of the Department of Biochemistry at the University of Washington. Nolen was the project's principal investigator.

The project was funded by grants from the National Institute of General Medical Sciences of the National Institutes of Health to Nolen and MacCoss. The project also utilized the National Science Foundation-supported Extreme Science and Engineering Discovery Environment.

(Story by Amy Connolly, adjunct instructor of biology, University of Oregon)

Source:

Brad Nolen
associate professor
Department of Chemistry and Biochemistry
541-346-7412
[email protected]

Links:

Nolen faculty page: http://molbio.uoregon.edu/nolen/

Nolen lab: https://blogs.uoregon.edu/nolenlab/

Institute of Molecular Biology: http://molbio.uoregon.edu/

Department of Chemistry and Biochemistry: https://chemistry.uoregon.edu/

Paper: http://www.pnas.org/content/115/7/E1409

Media Contact

Jim Barlow
[email protected]
541-346-3481
@UOregonNews

http://around.uoregon.edu

http://dx.doi.org/10.1073/pnas.1716622115

Share13Tweet7Share2ShareShareShare1

Related Posts

blank

SNARE Neofunctionalization Driven by Vacuole Retrieval

October 4, 2025
blank

Exploring Shigella Phage Sf14’s tRNA Contributions

October 3, 2025

Encapsulated Pseudomonas Controls Pistachio Gummosis Effectively

October 3, 2025

Scientists Uncover New Intracellular Trafficking Pathway in Plant Cells

October 3, 2025
Please login to join discussion

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    93 shares
    Share 37 Tweet 23
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    89 shares
    Share 36 Tweet 22
  • Physicists Develop Visible Time Crystal for the First Time

    75 shares
    Share 30 Tweet 19
  • New Insights Suggest ALS May Be an Autoimmune Disease

    68 shares
    Share 27 Tweet 17

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Electron Donor–Acceptor Complexes Enable Asymmetric Photocatalysis

Self-Efficacy Modulates Nurses’ Response to Abusive Supervision

SNARE Neofunctionalization Driven by Vacuole Retrieval

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 62 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.